576
Participants
Start Date
September 21, 2015
Primary Completion Date
March 31, 2017
Study Completion Date
March 31, 2017
DE-108
Subjects will be assigned to receive DE-108 ophthalmic solution to be administrated one drop a time 3 times daily for 3 days prior and for 14 days following cataract surgery.
Levofloxacin 0.5%
Subjects will be assigned to receive Levofloxacin 0.5% ophthalmic solution to be administrated one drop a time 3 times daily for 3 days prior and for 14 days following cataract surgery.
Kyungpook National University Hospital, Kyungpook
Asan Medical Center, Seoul
Kim's eye Hospital, Seoul
Seoul National University Bundang Hospital, Seoul
Seoul Saint Marry's Hospital, Seoul
Severance Hospital, Yonsei University Health System, Seoul
Santen Pharmaceutical Co., Ltd.
INDUSTRY